Progesterone Receptor Negative
Progesterone Receptor Negative - Related Videos
04:27
Isolation of Monocytes from Whole Blood by Immunomagnetic Negative Selection
0 Views •
2025
In this video, we demonstrate the isolation of monocytes from whole human blood by immunomagnetic negative separation. The isolated monocytes can be used for further downstream analysis.
01:23
Negative Regulator Molecules
0 Views •
2019
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria. Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e., cancer). These...
06:44
Confocal Imaging of Double-Stranded RNA and Pattern Recognition Receptors in Negative-Sense RNA Virus Infection
0 Views •
Cited by 12 •
2019
Double-stranded RNA produced during RNA virus replication can be recognized by pattern recognition receptors to induce an innate immune response. For negative-sense RNA viruses, the interaction between the low-level dsRNA and PRRs remains unclear. We have developed a confocal microscopy method to visualize arenavirus dsRNA and PRR in individual cells.
01:23
Negative Externalities
0 Views •
2025
A negative externality occurs when an economic transaction imposes unintended costs on third parties who are not directly involved in the market transaction. These external costs are not captured in the market price. Negative Externalities and Market Failure Consider a chemical manufacturing plant that produces industrial chemicals for sale. The plant's private costs include raw materials, labor, equipment, and maintenance, which are reflected in the market price of the chemicals. However,...
00:58
Positive, Negative, and Zero Work
0 Views •
2025
Work is done on an object when energy is transferred to the object. In other words, work is done when a force acts on a body that undergoes a displacement from one position to another. By definition, the work done by a force is the integral of the force with respect to the displacement along its path. Forces can vary as a function of position, and displacements can occur along various paths between two points. The magnitude of a force multiplied by the cosine of the angle that the force makes...
FAQs
Absent or very low immunohistochemical staining indicates that tumor cells have little or no detectable progesterone receptor protein. Consequently, progesterone-driven signaling is unlikely to be a major influence on the tumor’s behavior. This interpretation links a laboratory observation in tissue to a biological conclusion, while recognizing that the result describes receptor expression rather than every aspect of tumor biology.
Progesterone receptor status is interpreted as part of a broader hormone receptor and molecular profile, not in isolation. Clinicians consider it alongside estrogen receptor and HER2 testing when characterizing a breast tumor. This combined assessment provides a more complete framework for treatment planning than progesterone receptor findings alone.
Therapies that depend on hormone-receptor signaling may be less effective when progesterone receptor expression is absent or very low. The classification therefore helps clinicians judge whether that signaling pathway is likely to contribute to tumor behavior and whether treatment planning should account for reduced sensitivity to approaches relying on hormone-receptor activity.
Pathologists assess tumor tissue with immunohistochemistry, a staining-based method that reveals receptor protein. They interpret absent or very low staining as evidence supporting a negative classification. Because the conclusion depends on what is detectable in the sampled tissue, careful pathology assessment is important when receptor status is used in medical decision-making.
A progesterone receptor-negative classification can contribute to prognosis because it records whether detectable progesterone receptor expression is present in the tumor. Its value is greatest when interpreted with the other receptor findings, particularly estrogen receptor and HER2 results, rather than treated as a complete description of the disease.
Accurate pathology assessment supports treatment planning by characterizing hormone receptor status reliably. The resulting classification helps clinicians evaluate whether hormone-receptor signaling is likely to influence tumor behavior and select appropriate systemic treatment. This makes pathology assessment a clinically consequential step rather than merely a descriptive laboratory measurement.